Discover Tenders by Semi Finished Products Zinc Sector

Find the most relevant tenders for Semi Finished Products Zinc. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Semi Finished Products Zinc tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Semi Finished Products Zinc tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790984

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790983

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

A Dynamic System For Orders Of Specific Medical Consumables For The Needs Of Umbalsm N I Pirogov Ead

Deadline: 02 Apr 2027

Bulgaria

Ref. No.: 7786235

EMD:Ref Document

Bid Value: Ref Document

517 Days Left

2024 Department Of Homeland Security Dhs Directorate Of Science And Technology S T Long Range Broad Agency Announcement Lrbaa 24 01

Deadline: 31 May 2029

United States

Ref. No.: 7766242

EMD:Ref Document

Bid Value: Ref Document

1307 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir Atc Code J05Ar10

Deadline: 28 Jul 2026

Germany

Ref. No.: 7766088

EMD:Ref Document

Bid Value: Ref Document

269 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Telmisartan Atc Code C09Ca07

Deadline: 28 Jul 2026

Germany

Ref. No.: 7747295

EMD:Ref Document

Bid Value: Ref Document

269 Days Left

Silicon Valley Innovation Program 5 Year Other Transaction Solicitation

Deadline: 20 May 2026

United States

Ref. No.: 7710547

EMD:Ref Document

Bid Value: Ref Document

200 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Interferon Beta 1A L03Ab07 Subcutaneous Injection Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7708163

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen M01Ae02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7702625

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Rasagiline N04Bd02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7697176

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Miglustat A16Ax06 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7696670

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lacosamide N03Ax18 Excluding Film Coated Tablets Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7693028

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat M04Aa03 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7690242

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide C09Da24 Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7682368

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Timolol And Latanoprost S01Ed61 Within The Framework Of A So Called Open House Mod

Deadline: 31 Jul 2026

Germany

Ref. No.: 7681822

EMD:Ref Document

Bid Value: Ref Document

272 Days Left

Showing 54961 to 54975 of 55700 results

‹
1
2
...
3662
3663
3664
3665
3666
3667
3668
...
3713
3714
›

Discover Tenders by Semi Finished Products Zinc Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Semi Finished Products Zinc Sector

Filter Your Search

FREE Trial plan for all new users!